TXCELL S.A.Financial Statements • January 7th, 2019 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 7th, 2019 Company Industry
Sangamo Therapeutics, Inc. Unaudited Pro Forma Condensed Combined Financial StatementsShare Purchase Agreement • January 7th, 2019 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 7th, 2019 Company Industry